{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:45:54Z","timestamp":1789911954587,"version":"4.0.1"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/mcg.0b013e3182688d49","type":"journal-article","created":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T07:59:57Z","timestamp":1353052797000},"page":"256-257","source":"Crossref","is-referenced-by-count":34,"title":["Bevacizumab as Rescue Treatment for Severe Recurrent Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia"],"prefix":"10.1097","volume":"47","author":[{"given":"Alexandru","family":"Lupu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Stefanescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Treton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Corcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Bouhnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210305","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/lary.22501","article-title":"Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy.","volume":"122","author":"Karnezis","year":"2012","journal-title":"Laryngoscope"},{"key":"R2-15-20210305","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMc0901421","article-title":"Bevacizumab in hereditary hemorrhagic telangiectasia.","volume":"360","author":"Bose","year":"2009","journal-title":"N Engl J Med"},{"key":"R3-15-20210305","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary telangiectasia and severe hepatic vascular malformations and hight cardiac output.","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"},{"key":"R4-15-20210305","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/lt.21417","article-title":"Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.","volume":"14","author":"Mitchell","year":"2008","journal-title":"Liver Transpl"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0b013e3182688d49","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:09:59Z","timestamp":1620961799000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201303000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e3182688d49","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}